Assignee
PROMAB BIOTECHNOLOGIES INC
US·15 granted patents·7 pending applications·12 citations·filing 2017–2025
Top patents by PatentIndex Score
22 records- 0193US11034763B2Flag tagged CD19-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2018·Granted Jun 15, 2021·8 cites·8 claims
- 0290US11725053B2Chimeric antigen receptors comprising a human transferrin epitope sequencePROMAB BIOTECHNOLOGIES INC·Filed 2020·Granted Aug 15, 2023·2 cites·17 claims
- 0387US12540195B2CS1-antibody and anti-CS1-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Feb 3, 2026·1 cites·10 claims
- 0487US12227589B2Epcam antibody and Epcam-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Feb 18, 2025·1 cites·10 claims
- 0569US12552872B2Humanized BCMA antibody and BCMA-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2022·Granted Feb 17, 2026·0 cites·12 claims
- 0667US12448443B2CS1 antibody and anti-CS1-CAR-t cellsPROMAB BIOTECHNOLOGIES INC·Filed 2022·Granted Oct 21, 2025·0 cites·12 claims
- 0766US12173077B2Humanized BCMA antibody and BCMA-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2023·Granted Dec 24, 2024·0 cites·1 claims
- 0865US12545742B2Humanized CD37 and bi-specific CD19-humanized CD37 CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Feb 10, 2026·0 cites·3 claims
- 0965US12528873B2Humanized BCMA antibody and BCMA-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Jan 20, 2026·0 cites·11 claims
- 1065US12103970B2CAR-T cells with humanized CD19 ScFvPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Oct 1, 2024·0 cites·14 claims
- 1163US11692034B2CD47-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2019·Granted Jul 4, 2023·0 cites·10 claims
- 1263US10086055B2Adherent cancer cell line expressing a hematological tumor antigenPROMAB BIOTECHNOLOGIES INC·Filed 2017·Granted Oct 2, 2018·0 cites·3 claims
- 1361US12059436B2BCMA-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2020·Granted Aug 13, 2024·0 cites·9 claims
- 1461US12030957B2PLAP-CAR-effector cellsPROMAB BIOTECHNOLOGIES INC·Filed 2020·Granted Jul 9, 2024·0 cites·7 claims
- 1560US2022348688A1Plap-cd3 epsilon bispecific antibodiesPROMAB BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1659US2025388695A1Epcam-cd3 epsilon bispecific antibodiesPROMAB BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 1758US11332513B2Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domainPROMAB BIOTECHNOLOGIES INC·Filed 2019·Granted May 17, 2022·0 cites·7 claims
- 1856US2019015493A1Adherent cancer cell line expressing a hematological tumor antigenPROMAB BIOTECHNOLOGIES INC·Filed 2018·Application pending·0 cites
- 1955US2023227557A1Pd-l1-specific antibody and anti-pd-l1-car-t cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2055US2021340271A1Cd37-antibody and cd37-car-t cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2150US2025188415A1Nk cells transfected with car rna-lnpPROMAB BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 2245US2019023764A1Car having replicated binding motifs in a co-stimulatory domainPROMAB BIOTECHNOLOGIES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROMAB BIOTECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →